Article
Pten loss promotes MAPK pathway dependency in HER2/neu breast carcinomas
29 Feb 2016
Abstract excerpt
Loss of the tumor suppressor gene PTEN is implicated in breast cancer progression and resistance to targeted therapies, and is thought to promote tumorigenesis by activating PI3K signaling. In a transgenic model of breast cancer, Pten suppression using a tetracycline-regulatable short hairpin (sh)RNA cooperates with human epidermal growth factor receptor 2 (HER2/neu), leading to aggressive and metastatic disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
